Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2007
01/11/2007US20070010526 Therapeutic isoquinoline compounds
01/11/2007US20070010516 Novel piperidine derivatives
01/11/2007US20070010511 Organic compounds
01/11/2007US20070010509 Cycloamine ccr5 receptor antagonists
01/11/2007US20070010491 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye
01/11/2007US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
01/11/2007US20070010457 Caspase inhibitors and uses thereof
01/11/2007US20070007132 Transition metal complexes with bidentate ligand having an imidazole ring
01/11/2007CA2823088A1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
01/11/2007CA2614148A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
01/11/2007CA2614116A1 Histamine h3 receptor antagonists
01/11/2007CA2613435A1 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation
01/11/2007CA2613236A1 G-protein coupled receptor agonists
01/11/2007CA2613235A1 Gpcr agonists
01/11/2007CA2613192A1 Histamine h3 receptor agents, preparation and therapeutic uses
01/11/2007CA2613045A1 Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation
01/11/2007CA2612893A1 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders
01/11/2007CA2612612A1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
01/11/2007CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
01/11/2007CA2611688A1 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
01/10/2007EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
01/10/2007EP1741710A1 Pyrrolidine derivative
01/10/2007EP1741709A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
01/10/2007EP1741708A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
01/10/2007EP1741703A1 Pyridone derivative
01/10/2007EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
01/10/2007EP1741428A2 Cell adhesion inhibitors
01/10/2007EP1740581A1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer"s disease
01/10/2007EP1740578A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
01/10/2007EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
01/10/2007EP1740576A1 Novel piperidine substituted diaminothiazoles
01/10/2007EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors
01/10/2007EP1740574A2 4-amino-5-cyanopyrimidine derivatives
01/10/2007EP1740573A1 Amides as bace inhibitors
01/10/2007EP1740572A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
01/10/2007EP1740571A1 A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers
01/10/2007EP1740570A2 Novel gamma secretase inhibitors
01/10/2007EP1740569A1 Imidazole derivatives used as tafia inhibitors
01/10/2007EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives
01/10/2007EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
01/10/2007EP1740550A1 Sulphur-linked imidazole compounds for the treament of hiv
01/10/2007EP1740549A2 Novel imidazoles
01/10/2007EP1740548A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
01/10/2007EP1740547A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
01/10/2007EP1740544A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
01/10/2007EP1740538A2 Bicyclic heterocycles useful as serine protease inhibitors
01/10/2007EP1740306A1 Use of metal complexes having bispyridylpyrimidine or bispyridyltriazine ligands as catalysts for reactions with peroxy compounds for bleaching coloured stains on hard surfaces
01/10/2007EP1740185A1 Benzodiazepines for treating or preventing rsv infection
01/10/2007EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase
01/10/2007EP1200073B1 SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
01/10/2007EP1109803B1 Substituted imidazoles having cytokine inhibitory activity
01/10/2007EP1066259B1 Biocidal benzylbiphenyl derivatives
01/10/2007CN1894274A Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
01/10/2007CN1894240A 阿片受体拮抗剂 Opioid receptor antagonist
01/10/2007CN1894239A Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
01/10/2007CN1894238A Diamine derivatives
01/10/2007CN1894237A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
01/10/2007CN1894236A Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
01/10/2007CN1894235A N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
01/10/2007CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors
01/10/2007CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels
01/10/2007CN1894212A Near-infrared fluorescent contrast medium
01/10/2007CN1894210A Prolinylarylacetamides
01/10/2007CN1894190A Method for the production of tetrahydrogeranylacetone
01/10/2007CN1893951A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
01/10/2007CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
01/10/2007CN1893945A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
01/10/2007CN1893825A Substituted arylpyrazoles as parasiticidal agents
01/10/2007CN1891701A Heteraromatic ring thiosemicarbazone compound, and its derivatives and their use forpreparing antitumour medicine
01/10/2007CN1891696A Dissymmetrical diazo compounds, compositions comprising them, method of coloring, and device
01/10/2007CN1891695A Symmetrical diazo compounds, compositions comprising them, method of coloring, and device
01/10/2007CN1891692A Dyssymmetrical diazo compounds, compositions comprising them, method of coloring, and device
01/10/2007CN1891691A Symmetrical diazo compounds, compositions comprising them, method of coloring, and device
01/10/2007CN1891689A Aliphatic nitrogen - containing 5 - membered ring compound
01/10/2007CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
01/10/2007CN1294180C Preparation method of poly (diimide ether)
01/10/2007CN1294131C Pyrimidine compound
01/10/2007CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof
01/10/2007CN1293880C Aqueous liquid preparations and light-stabilized aqueous liquid preparations
01/09/2007US7161009 Antiinflammatory agents; skin disorders; central nervous system disorders
01/09/2007US7160966 Polymerizable composition with free radicals and by controlling polymerization
01/09/2007US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
01/09/2007US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors
01/09/2007US7160907 Pleuromutilin derivatives
01/09/2007US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis
01/09/2007US7160903 Sulfonylaminocarboxylic acids
01/09/2007US7160902 Amide derivatives and methods of their use
01/09/2007US7160901 Antiproliferative agents; antitumor agents; kinase inhibitors
01/09/2007US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives
01/09/2007US7160897 Therapeutic compounds
01/09/2007US7160896 Therapeutic acridone and acridine compounds
01/09/2007US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors
01/09/2007US7160891 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
01/09/2007US7160889 Quinazoline compounds
01/09/2007US7160887 Aromatic amine derivatives, their production and use
01/09/2007US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction
01/09/2007US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
01/09/2007US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
01/09/2007US7160878 Substituted heterocyclic amides
01/09/2007US7160877 Aliphatic nitrogen-containing 5-membered ring compound